Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current Neurology and Neuroscience Reports
Erschienen in: Current Neurology and Neuroscience Reports 2/2011

01.04.2011

Moyamoya Disease and Surgical Intervention

verfasst von: Jay W. Rhee, Suresh N. Magge

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Stroke is an increasingly recognized cause of morbidity in the pediatric population. The incidence of ischemic stroke is 1.2 per 100,000 children. There are many known etiologies of childhood cerebral ischemia but moyamoya is one of the only ischemic conditions of childhood that can be effectively treated with surgery. Moyamoya disease is by definition idiopathic, whereas moyamoya syndrome refers to a similar disease course in conjunction with a known predisposing condition. The clinical manifestations and disease progression are similar. Furthermore, surgical treatment has been shown to be efficacious and safe in the treatment of moyamoya.
Literatur
1.
Fullerton HJ, Wu YW, Zhao S, et al.: Risk of stroke in children: ethnic and gender disparities. Neurology 2003, 61:189–194.PubMed
2.
• Roach ES, Golomb MR, Adams R, et al.: Management of stroke in infants and children: a scientific statement from a special writing group of the American heart association stroke council and the council on cardiovascular disease in the young. Stroke 2008, 39:2644–2691. This paper resulted from the efforts of a multidisciplinary panel of physicians appointed by the American Heart Association Stroke Council’s Scientific Statement Oversight Committee. The writers provide an extensive review of the literature regarding childhood stroke along with specific diagnostic and treatment recommendations stratified according to strength of evidence. PubMedCrossRef
3.
4.
5.
Takeuchi K, Shimizu K: Hypoplasia of the bilateral internal carotid arteries. Brain Nerve 1957, 9:37–43.
6.
Suzuki J, Takaku A: Cerebrovascular moyamoya disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969, 20:288–299.PubMed
7.
Karasawa J, Kikuchi H, Furuse S, et al.: Treatment of moyamoya disease with STA-MCA anastomosis. J Neurosurg 1978, 49:679–688.PubMedCrossRef
8.
Wakai K, Tamakoshi A, Ikezaki K, et al.: Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg 1997, 99(2):S1–S5.PubMedCrossRef
9.
Kuriyama S, Kusaka Y, Fujimura M, et al.: Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings fro a nationwide epidemiological survey. Stroke 2008, 32:42–47.CrossRef
10.
Baba T, Houkin K, Kuroda S: Novel epidemiological features of moyamoya disease. J neurol Neurosurg Psychiatry 2008, 79:900–904.PubMedCrossRef
11.
• Scott RM, Smith JL, Robertson RL, et al.: Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synagniosis. J Neurosurg (Pediatrics 2) 2004, 100:142–149. Scott et al presents the largest series available regarding the surgical treatment of childhood moyamoya. 143 enrolled subjects were characterized based on epidemiological factors and symptoms at presentation and subsequently underwent pial synangiosis. Long term postsurgical followup revealed the efficacy of pial synangiosis in the treatment of childhood moyamoya.CrossRef
12.
Uchino K, Johnston SC, Becker KJ, et al.: Moyamoya disease in Washington state and California. Neurology 2005, 65:956–958.PubMedCrossRef
13.
Nagaraja D, Verma A, Taly AB, et al.: Cerebrovascular disease in children. Acta Neurol Scand 1994, 90(4):251–255.PubMedCrossRef
14.
Scott RM, Smith ER: Moyamoya disease and moyamoya syndrome. N Engl J Med 2009, 360:1226–1237. This is an excellent review of the disease process of moyamoya. PubMedCrossRef
15.
Fukui M: Guidelines for the diagnosis and the treatment of spontaneous occlusion of the circle of Willis (‘Moyamoya disease’). Clin Neurol Neurosurg 1997, 99(2):S238–S240.PubMed
16.
Ullrich NJ, Robertson R, Kinnamon DD, et al.: Moyamoya following cranial irradiation for primary brain tumors in children. Neurology 2007, 68:932–938.PubMedCrossRef
17.
Rosser TL, Vezina G, Packer R: Cerebrovascular abnormalities in a population of children with neurofibromatosis. Neurology 2005, 64:553–555.PubMed
18.
Jea A, Smith ER, Robertson R, Scott RM: Moyamoya syndrome associated with down syndrome:outcome after surgical revascularization. Pediatrics 2005, 116:e694–e701.PubMedCrossRef
19.
Hankinson TC, Bohman LE, Heyer G, et al. : Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis. J Neurosurg Pediatrics 2008, 1:211–216.CrossRef
20.
Servo A, Puranen M: Moyamoya syndrome as a complication of radiation therapy. J Neurosurg 1978, 48:1026–1029.PubMedCrossRef
21.
Okuno T, Prensky AL, Gado M: The Moymoya syndrome associated with irradiation of an optic glioma in children: report of two cases and review of the literature. Pediat Neurol 1985, 1:311–316.PubMedCrossRef
22.
23.
Hirotsune N, Meguro T, Kawada S, et al.: Long-term follow-up study of patients with unilateral moyamoya disease. Clin Neurol Neurosurg 1997, 99(2):S178–S181.PubMed
24.
Smith ER, Scott RM: Progression of disease in unilateral moyamoya syndrome. Neurosurg Focus 2008, 24(2):E17.PubMedCrossRef
25.
Fukui M, Kono S, Sueishi K, et al.: Moyamoya disease. Neuropathology 2000, 20 suppl:S61–64.PubMedCrossRef
26.
Yamauchi T, Houkin K, Tada M, Abe H: Familial inheritance of moyamoya disease. Clin Neurol Neurosurg 1997, 99(2):S162–S167.PubMed
27.
Ikeda H, Sasaki T, Yoshimoto T, et al.: Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 1999, 64:533–537.PubMedCrossRef
28.
Yamauchi T, Tada M, Houkin K, et al.: Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 2000, 31:930–935.PubMed
29.
Sakurai K, Horiuchi Y, Ikeda H et al.: A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet 2004, 49:278–281.PubMedCrossRef
30.
Inoue TK, Ikezaki K, Sasazuki T et al.: Linkage analysis of moyamoya disease on chromosome 6. J child neurol 2000, 15:179–182.PubMedCrossRef
31.
Yonekawa Y, Ogata N, Kaku Y, et al.: Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg 1997, 99(2):S58–S60.PubMedCrossRef
32.
Graham J, Matoba A: A survey of moyamoya disease in Hawaii. Clin Neurol Neurosurg 1997, 99(2):S31–35.PubMedCrossRef
33.
Smith JL.: Understanding and treating moyamoya disease in children. Neurosurg Focus 2009, 26(4):E4.PubMedCrossRef
34.
• Fung LE, Thompson D, Ganesan V: Revascularization surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst 2005, 21:358–364. The literature regarding direct, indirect and combined surgical procedures was reviewed. Patient characteristics, presenting symptoms, indications for surgery and outcomes of surgery were reported in a pooled analysis. The authors concluded that surgical revascularization was indeed efficacious. Although direct and combined procedures resulted in superior revascularization based of postoperative radiographic evidence, clinical outcomes were not statistically different.PubMedCrossRef
35.
Tagawa T, Naritomi H, Mimaki T, et al.: Regional cerebral blood flow, clinical manifestations, and age in children with moyamoya disease. Stroke 1987, 18:906–910.PubMed
36.
Kansha M, Irita K, Takahashi S, et al.: Anesthetic management of children with moyamoya disease. Clin Neurol Neurosurg 1997, 99(2):S110–113.PubMed
37.
Kodama N, Aoki Y, Hiraga H, et al.: Electroencephalographic findings in children with moyamoya disease. Arch Neurol 1979, 36(1):16–19.PubMed
38.
Fujiwara J, Nakahara S, Enomoto T, et al.: The effectiveness of O2 administration for transient ischemic attacks in moyamoya disease in children. Childs Nerv Syst 1996, 12(2):69–75.PubMedCrossRef
39.
Iwama T, Hashimoto N, Yonekawa Y: The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease. Neurosurgery 1996, 38(6):1120–1126.PubMedCrossRef
40.
Nomura S, Kashiwagi S, Uetsuka S, et al.: Perioperative management protocols for children with moyamoya disease. Childs Nerv Syst 2001, 17(4–5):270–274.PubMedCrossRef
41.
Seol HJ, Wang KC, Kim SK: Headache in pediatric moyamoya disease: review of 204 consecutive cases. J Neurosurg (Pediatrics) 2005, 103(5):439–442.CrossRef
42.
Lichtor T, Mullan S: Arteriovenous malformation in moyamoya syndrome. J Neurosurg 1987, 67:603–608.PubMedCrossRef
43.
Kodama N, Suzuki J: Moyamoya disease associated with aneurysm. J Neurosurg 1978, 48:565–569.PubMedCrossRef
44.
Takagi Y, Kikuta K, Nozaki K: Histological features of middle cerebral arteries from patients treated for moyamoya disease. Neurol Med Chir (Tokyo) 2007, 47:1–4.CrossRef
45.
Hosada Y, Ikeda E, Hirose S: Histopathological studies on spontaneous occlusion of the circle of Willis(cerebrovascular Moyamoya disease). Clin Neurol Neurosurg 99 (suppl 2) 1997, S203–S208.
46.
Kono S, Oka K, Sueishi K, et al.: Histopathological studies on spontaneous vault Moyamoya and revascularized collaterals formed by encephalomyosynangiosis. Clin Neurol Neurosurg 1997, 99(2):S209–S212.PubMedCrossRef
47.
Yamada I, Suzuki S, Matsushima Y: Moyamoya disease: comparison of assessment with MR angiography and MR imaging versus conventional angiography. Radiology 1995, 196:211–218.PubMed
48.
Tomoichi I, Kitami H, Kayoko S, et al.: Long-term outcomes of pediatric moyamoya disease moitored to adulthood. Pediat Neurol 1998, 18(4):321–325.CrossRef
49.
Kurokawa T, Tomita S, Ueda K, et al.: Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children. Pediat Neurol 1985, 1(5):274–247.PubMedCrossRef
50.
Karasawa J, Kikuchi H, Furuse S, et al.: Treatment of moyamoya disease with STA-MCA anastomosis. J Neurosurg 1978, 49:679–688.PubMedCrossRef
51.
Hosain SA, Hughes JT, Forem SL, et al.: Use of a calcium channel blocker (nicardipine HCL) in the treatment of childhood moyamoya disease. J Child Neurol 1994, 9(4):378–380.PubMedCrossRef
52.
Matsushima T, Inoue T, Suzuki SO: Surgical treatment of moyamoya disease in pediatric patients-comparison between the results of the indirect and direct revascularization procedures. Neurosurgery 1992, 31:401–405.PubMedCrossRef
53.
Suzuki J, Takaku A, Kodama N, et al.: An attempt to treat cerebrovascular ‘Moyamoya’ disease in children. Childs Brain 1975, 1:193–206.PubMed
54.
Donaghy RM: Neurologic surgery. Surg Gynecol Obstet 1972, 134:269–270.PubMed
55.
Iwama T, Hashimoto N, Tsukahara, et al.: Superficial temporal artery to anterior cerebral artery direct anastomosis in patients with moyamoya disease. Clin Neurol Neurosurg 1997, 99(2):S134–S136.PubMed
56.
Kawashima A, Kawamata T, Yamaguchi K, et al.: Successful superficial temporal artery-anterior cerebral artery direct bypass using a long graft for moyamoya disease: technical note. Neurosurgery 2010, 67(ONS suppl 1): ons145–ons149.PubMedCrossRef
57.
Wanebo JE, Zambramski JM, Spetzler RF: Superficial temporal artery-to-middle cerebral artery bypass grafting for cerebral revascularization. Neurosurgery 2004, 55:395–399.PubMedCrossRef
58.
Matsushima Y, Fukai N, Tanaka K, et al.: A new operative method for “Moya-moya” disease. A presentation of a case who underwent encephalo-duro-arterio (STA)-synangiosis. Nerv Syst Child 1981, 5:249–255.
59.
Scott RM, Smith ER: Moyamoya syndrome in children with pial synangiosis. In Neurosurgical Operative Atlas: Pediatric Neurosurgery. Edited by Goodrich JT. New York: Thieme Medical Publishers; 2008:171–176.
60.
Reiss CVC, Safavi-Abbasi S, Zambramski JM, et al.: The history of neurosurgical procedures for moyamoya disease. Neurosurg Focus 2006, 20(6): E7.
61.
Kuroda S, Houkin K, Ishikawa T, et al.: Novel bypass surgery for moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome. Neurosugery 2010, 66:1093–1101.CrossRef
62.
Tu YK, Liu HM, Kuo MF, et al.: Combined encephalo-arterio-synangiosis and encephalo-,yo-synangiosis in the treatment of moyamoya disease. Clin Neurol Neurosurg 1997, 99(2):S118–S122.PubMed
63.
Kashiwagi S, Kato S, Yamashita K, et al.: Revascularization with split duro-encephalo-synangiosis in the pediatric Moyamoya disease- surgical result and clinical outcome. Clin Neurol Neurosurg 1997, 99(2):S115–S117.PubMed
64.
Sakamoto H, Kitano S, Yasui T: Direct extracranial-intracranial bypass for children with moyamoya disease. Clin Neurol Neurosurg 1997, 99(2):S128–S133.PubMed
65.
Veeravagu A, Guzman R, Patil CG, et al.: Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions. Neurosurg Focus 2008, 24(2):E16.PubMedCrossRef
66.
Kawaguchi S, Okuno S, Sakaki T: Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. J Neurosurg 2000, 93:397–401.PubMedCrossRef
67.
Matsushiima T, Inoue T, Ikezaki K, et al.: Multiple combined indirect procedure for the surgical treatment of children with moyamoya disease. A comparison with single indirect anastomosis and direct anastomosis. Neurosurg Focus 1998, 15(5):e4.
68.
Houkin K, Ishikawa T, Yoshimoto T, et al.: Direct and indirect revascularization for moyamoya disease surgical techniques and peri-operative complications. Clin Neurol Neurosurg 1997, 99(2):S142–S145.PubMedCrossRef
69.
Matsushima Y, Aoyagi M, Nariai T, et al.: Long-term intelligence outcome of post-encephalo-duro-arterio-synagiosis childhood Moyamoya patients. Clin Neurol Neurosurg 1997, 99(2):S147–S150.PubMed
70.
Choi JU, Kim DS, Kim EY, et al.: Natural history of Moyamoya disease: comparison of activity of daily living in surgery and non surgery groups. Clin Neurol Neuosurg 1997, 99(2):S11–S18.CrossRef
71.
Houkin K, Kamiyama H, Abe H, et al.: Surgical therapy for adult moyamoya disease. Stroke 1996, 27:1342–1346.PubMed
Metadaten
Titel
Moyamoya Disease and Surgical Intervention
verfasst von
Jay W. Rhee
Suresh N. Magge
Publikationsdatum
01.04.2011
Verlag
Current Science Inc.
Erschienen in
Current Neurology and Neuroscience Reports / Ausgabe 2/2011
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-010-0173-8

Weitere Artikel der Ausgabe 2/2011

Current Neurology and Neuroscience Reports 2/2011 Zur Ausgabe

ReviewPaper

Ocular and Orbital Pain for the Headache Specialist

ReviewPaper

Molecular Genetics of Neuronal Migration Disorders

Clinical trial report

High-Flow Oxygen: A Gladly Received Fresh Look at an Old but Effective Abortive Treatment for Cluster Headache

Clinical Trial Report

Risk Stratification of Medulloblastoma: A Paradigm for Future Childhood Brain Tumor Management Strategies

ReviewPaper

Asymptomatic Sleep Abnormalities Are a Common Early Feature in Patients with Huntington’s Disease

ReviewPaper

The Association of Pituitary Tumors and Headache

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise